Policy

Consent & Risk Disclosure Policy

Informed consent, capacity assessment and risk disclosure for aesthetic treatments and procedures

For Aesthetic ClinicRef BS-AES-POL-004See a sample (PDF) →
£54.99
One-off purchase · no VAT · instant download
  • Instant download after checkout
  • Editable Microsoft Word (.docx)
  • Mapped to the CQC standards
  • Optional 3-monthly updates

What's inside

This policy is fully drafted and structured, ready to brand and complete for your service. It covers:

  • 1. Purpose
  • 2. Scope
  • 3. Policy statement
  • 4. Definitions
  • 5. The consent process: a staged pathway
  • 6. Photography, data and financial consent
  • 7. When things go wrong: duty of candour
  • 8. Roles and responsibilities
  • 9. Training
  • 10. Records, monitoring and audit
  • 11. Related documents
  • 12. Appendix A - Pre-treatment consent checklist
  • 13. Appendix B - Consent record form (summary)
  • 14. Version control and review
  • 15. Disclaimer

Legislation & standards it maps to

  • Health and Social Care Act 2008 (Regulated Activities) Regulations 2014, Regulation 11 (Need for consent)
  • Health and Social Care Act 2008 (Regulated Activities) Regulations 2014, Regulation 9 (Person-centred care) and Regulation 12 (Safe care and treatment)
  • Health and Social Care Act 2008 (Regulated Activities) Regulations 2014, Regulation 20 (Duty of candour)
  • Mental Capacity Act 2005 and the Mental Capacity Act 2005 Code of Practice
  • Montgomery v Lanarkshire Health Board [2015] UKSC 11 (material risk standard)
  • UK General Data Protection Regulation and the Data Protection Act 2018
  • Human Medicines Regulations 2012 (prescribing and supply of prescription-only medicines)
  • Care Quality Commission (Registration) Regulations 2009, Regulation 18 (Notification of other incidents)

Who it applies to

All registered managers, clinical leads, prescribers, practitioners (medical, nursing, dental and non-medical aesthetic practitioners), receptionists and administrative staff involved in patient pathways at [Organisation Name]

Glossary

Plain-English explanations of the technical terms and legislation used in this document.

Adverse reaction
An unexpected or harmful response to a treatment, medicine or product.
Anaphylaxis
A severe, life-threatening allergic reaction needing immediate emergency treatment.
Biofilm
A layer of bacteria that can form around a filler or implant and cause a stubborn, hard-to-treat infection.
Body dysmorphic disorder
A mental health condition in which a person is preoccupied with perceived flaws in their appearance that others may not notice.
Botulinum toxin
A prescription-only medicine injected to relax muscles and soften lines, commonly used in aesthetic treatments.
Capacity (mental capacity)
Whether a person can understand and make a particular decision for themselves at the time it needs to be made.
Care Quality Commission (CQC)
The independent regulator of health and social care services in England.
Contraindication
A condition or factor that makes a particular treatment unsafe or unsuitable for that patient.
Cooling-off period
A set time between agreeing to treatment and having it, so the patient can reflect without pressure.
Data Protection Act 2018
The UK law that sits alongside the UK General Data Protection Regulation and governs how personal information is handled.
Dermal filler
A gel-like substance injected under the skin to smooth lines or add volume.
Duty of candour
The legal duty to be open and honest with a person and their family when something goes wrong with their care.
Erythema
Redness of the skin caused by treatment, irritation or inflammation.
Extrusion
When a thread or implant works its way out through the skin.
Gillick competence
A test of whether a person under 18 understands a decision well enough to consent to treatment themselves.
Health and Social Care Act 2008 (Regulated Activities) Regulations 2014
The regulations setting out the fundamental standards that registered care providers must meet, enforced by the Care Quality Commission.
High-intensity focused ultrasound (HIFU)
A device that uses focused sound-wave energy to heat deeper layers of skin for tightening or lifting.
Human Medicines Regulations 2012
The main UK law controlling how medicines are prescribed, supplied and administered.
Hyaluronidase
An injectable enzyme used to dissolve dermal filler, including in emergencies such as a blocked blood vessel.
Hyperpigmentation
Patches of skin that become darker than the surrounding area, sometimes after treatment.
Informed consent
Agreement to treatment given freely after the risks, benefits and alternatives have been clearly explained.
Intense pulsed light (IPL)
A device that uses broad-spectrum light to treat the skin, for example for pigmentation or hair removal.
Material risk
A risk that a reasonable patient in that person's position would want to know about before deciding on treatment.
Mental Capacity Act 2005
The law that protects and supports people who may be unable to make particular decisions for themselves.
Mental Capacity Act 2005 Code of Practice
Official guidance explaining how to apply the Mental Capacity Act 2005 in day-to-day practice.
Microneedling
A treatment that uses fine needles to make tiny punctures in the skin to encourage repair and renewal.
Montgomery v Lanarkshire Health Board [2015] UKSC 11
A Supreme Court ruling that established the legal duty to disclose any risk a reasonable patient would consider significant.
Necrosis
The death of skin or tissue, which can follow a blocked blood vessel after filler injection.
Nominated Individual
The senior person responsible to the regulator for supervising how a service is provided.
Notifiable safety incident
A patient safety event a provider is legally required to be open about and, where applicable, report to the regulator.
Prescriber assessment
A check by a qualified prescriber to decide whether a prescription-only medicine is suitable for a patient.
Prescription-only medicine (POM)
A medicine that may lawfully be supplied only on the instruction of an appropriate prescriber.
Ptosis
Drooping of the brow or eyelid, which can occur as a side effect of botulinum toxin treatment.
Radiofrequency (RF)
A device that uses radio-wave energy to heat the skin for tightening or rejuvenation.
Registered Manager
The person registered with the regulator as responsible for the day-to-day running of a service.
Regulated activity
A type of care or treatment the law requires a provider to register with the regulator to deliver.
Single assessment framework
The structure the regulator uses to judge a service, built around quality statements and five key questions (safe, effective, caring, responsive, well-led).
Teach-back
A method of checking understanding by asking the patient to explain back, in their own words, what they have been told.
UK General Data Protection Regulation (UK GDPR)
The UK's main data-protection law governing how personal information is collected and used.
Vascular occlusion
A blockage of a blood vessel, a serious complication of filler injection that needs immediate treatment.

How it works

  1. Buy securely with Stripe - instant, no VAT, no account needed.
  2. Download your editable Word file from the link we email you straight away.
  3. Complete the placeholders for your service, then have it approved before use.
  4. Add the optional updates subscription and we keep it current as guidance changes.

Related documents

PolicyAdverse Event Management Policy£54.99
PolicySafeguarding Policy£54.99
PolicyComplaints Policy£54.99
PolicyHealth & Safety Policy£54.99

Need the whole set?

Buy the full Aesthetic Clinic pack and save versus buying documents individually.

View the Aesthetic Clinic pack